cagrilintide peptide for weight loss Let me introduce you to a NEW 𝐕𝐈𝐏 𝐂𝐀𝐆𝐑𝐈𝐋𝐈𝐍𝐓𝐈𝐃𝐄 𝐓𝐞𝐥𝐥 𝐦𝐞 𝐦𝐨𝐫𝐞 📣: is an amylin-analog which is now being developed in combination with GLP-1 agonist Semaglutide to achieve sustained Cagrilintide Peptide – Appetite Regulation

Paniagua R, Sharpe O, Ho P, et al

By gene profiling of aorta samples and evaluation of anti-inflammatory properties of semaglutide in an acute in vivo inflammation model Rakipovski G, et al

Disclosure of interest: Nothing to disclose E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P2217 - ESOC25-715 OUTCOMES OF STROKE PATIENTS ADMITTED FROM LONG TERM CARE INSTITUTIONS AND NURSING HOMES Amy Lynch 1 , Joan McCormack 2 , Olga Brych 2 , Rnn Collins 3 , Tim Cassidy 2,4 , Joseph Harbison 1,2,5 1 St James's Hospital, Dublin, Ireland, 2 Irish National Audit of Stroke, National Office for Clinical Audit, Dublin 2, Ireland, 3 The National Clinical Programme for Stroke, Health Service executive, Dublin, Ireland, 4 St Vincent's University Hospital, Dublin 4, Ireland, 5 Trinity College Dublin, Dublin 2, Ireland Background and Aims: 3.5% of Irish people 65 years live in Long Term Care (LTC) centres

Incorrect Storage: Leaving reconstituted peptides at room temperature or in a fluctuating environment (like a fridge door) will rapidly degrade them

Others use NSAIDs for acute flares while relying on peptides for ongoing support

Timing Optional Monitoring guidance is label-informed for tirzepatide and supported by incretin-class clinical monitoring considerations